BAM
Blueshift Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,226
| Closed | -$406K | – | 542 |
|
|
2025
Q1 | $406K | Buy |
+1,226
| New | +$406K | 0.16% | 203 |
|
|
2024
Q4 | – | Sell |
-1,852
| Closed | -$393K | – | 456 |
|
|
2024
Q3 | $393K | Buy |
+1,852
| New | +$393K | 0.1% | 231 |
|
|
2023
Q3 | – | Sell |
-3,139
| Closed | -$725K | – | 369 |
|
|
2023
Q2 | $725K | Buy |
3,139
+808
| +35% | +$187K | 0.28% | 90 |
|
|
2023
Q1 | $565K | Buy |
+2,331
| New | +$565K | 0.24% | 123 |
|
|
2022
Q2 | – | Sell |
-4,348
| Closed | -$427K | – | 885 |
|
|
2022
Q1 | $427K | Buy |
+4,348
| New | +$427K | 0.04% | 490 |
|